CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA
Year: 2022
Type: article
Abstract: The all-protein cytosine base editor DdCBE uses TALE proteins and a double-stranded DNA-specific cytidine deaminase (DddA) to mediate targeted C•G-to-T•A editing. To improve editing efficiency and overcome the strict TC sequence-context constraint of DddA, we used phage-assisted non-continuous and continuous evolution to evolve DddA variants with improved activity and expanded targeting scope. Compared to canonical DdCBEs, base editors with evolved DddA6 improved mitochondrial DNA (mtDNA) editing efficiencies at TC by 3.3-fold on average. DdCBEs containing evolved DddA11 offered a broadened HC (H = A, C or T) sequence compatibility for both mitochondrial and nuclear base editing, increasing average editing efficiencies at AC and CC targets from less than 10% for canonical DdCBE to 15-30% and up to 50% in cell populations sorted to express both halves of DdCBE. We used these evolved DdCBEs to efficiently install disease-associated mtDNA mutations in human cells at non-TC target sites. DddA6 and DddA11 substantially increase the effectiveness and applicability of all-protein base editing.
Source: Nature Biotechnology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $11,390
Funders: National Science Foundation, Howard Hughes Medical Institute, U.S. Department of Health and Human Services, Jane Coffin Childs Memorial Fund for Medical Research, National Institutes of Health, National Human Genome Research Institute, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering
Awards: G2304256781, Harvard Chemical Biology Graduate Program, G3405342043, G3549828030, Expanding the Scope of Base Editing, G4630203202, G6316350344, G6855349143, Continuous Evolution of Proteins with Novel Therapeutic Potential, Mitochondrial Parts, Pathways, and Pathogenesis, ePACE: automation platforms for adaptable and scalable continuous evolution of biomolecules with therapeutic potential, Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics, Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease
OpenAlex ID: W4225835566
